Who Buys Glibenclamide from India — 335 Importers Behind a $41.2M Market
India's glibenclamide import market is served by 335 active buyers who collectively imported $41.2M across 930 shipments. A,BAUR & CO,(PVT,) LTD (SRI LANKA) leads with a 89.7% market share, followed by PJSC PHARMSTANDARD-TOMSKHIMPHARM and OPHAM. The top 5 buyers together control 91.3% of total import value, reflecting a concentrated buyer landscape.
Top Glibenclamide Importers — Ranked by Import Value
A,BAUR & CO,(PVT,) LTD (SRI LANKA) is the leading glibenclamide importer from India, holding a 89.7% share of the $41.2M market across 930 shipments from 335 buyers. The top 5 buyers — A,BAUR & CO,(PVT,) LTD (SRI LANKA), PJSC PHARMSTANDARD-TOMSKHIMPHARM (RUSSIA), OPHAM (MADAGASCAR), M/S. IMRES (NETHERLANDS), PJSC "PHARMSTANDARD-TOMSKHIMPHARM" (RUSSIA) — collectively control 91.3% of total import value.
Top Glibenclamide Buyers & Importers
Ranked by import value · 335 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | A,BAUR & CO,(PVT,) LTDSRI LANKA GLIBENCLAMIDE TABLET 5 MG BP 1000'S PAC | $37.0M | 5 | 89.7% |
| 2 | PJSC PHARMSTANDARD-TOMSKHIMPHARMRUSSIA GLUCONORM TABLETS (GLIBENCLAMIDE 2.5 MGGLUCONORM TABLETS 118600 PACKS OF 20 TABSGLUCONORM TABLETS [GLIBENCLAMIDE 2.5 MG | $183.7K | 5 | 0.4% |
| 3 | OPHAMMADAGASCAR GLINIL 5MG TABLET [540X10X10'S]GLINIL 5MG TABLET [1GLINIL 5MG TABLET [4 | $181.8K | 5 | 0.4% |
| 4 | M/S. IMRESNETHERLANDS GLUCONORM TABLETS (GLIBENCLAMIDE 2.5 MGGLUCORED FORTE TABLETS(GLIBENCLAMIDE 5MGGLUCONORM TABLETS 118600 PACKS OF 20 TABS | $142.4K | 5 | 0.3% |
| 5 | PJSC "PHARMSTANDARD-TOMSKHIMPHARM"RUSSIA GLUCONORM TABLETS (GLIBENCLAMIDE 2.5 MGGLUCONORM TABLETS 118600 PACKS OF 20 TABSGLUCONORM TABLETS [GLIBENCLAMIDE 2.5 MG | $116.3K | 5 | 0.3% |
| 6 | OETHMAAN BIOSIMS PTY LIMITEDSOUTH AFRICA GLIBENCLAMIDE 5 OETHMAAN TABLETS PRP56GLIBENCLAMIDE 5 OETHMAANTABLETS PRP56GLIBENWISE 5 (GLIBENCLAMIDE TABLETS BP 5 | $114.5K | 5 | 0.3% |
| 7 | BIOTECH LABORATORIES (PTY) LTDSOUTH AFRICA GLIBENCLAMIDE 5 OETHMAAN TABLETS PRP56GLIBENCLAMIDE 5 OETHMAANTABLETS PRP56GLIBENWISE 5 (GLIBENCLAMIDE TABLETS BP 5 | $81.1K | 5 | 0.2% |
| 8 | OETHMAAN BIOSIMS PTY LTDSOUTH AFRICA GLIBENCLAMIDE 5 OETHMAAN TABLETS PRP56GLIBENCLAMIDE 5 OETHMAANTABLETS PRP56GLIBENWISE 5 (GLIBENCLAMIDE TABLETS BP 5 | $69.2K | 5 | 0.2% |
| 9 | XXTHMXXN BXXSIMXXPTYXXTDSOUTH AFRICA GLIBENCLAMIDE 5 OETHMAAN TABLETS PRP56GLIBENCLAMIDE 5 OETHMAANTABLETS PRP56GLIBENWISE 5 (GLIBENCLAMIDE TABLETS BP 5 | $61.5K | 5 | 0.1% |
| 10 | SAUDI HOSPITAL IN HAJJAH SHHYEMEN | $58.2K | 5 | 0.1% |
| 11 | UNIVERSAL MARKETING ASSOCIATES,SANICARAGUA | $54.3K | 5 | 0.1% |
| 12 | HEKO PHARMACY LTDTANZANIA GLUCORED FORTE TABLETS(GLIBENCLAMIDE 5MGGLUCORED FORTE TABLETS GLIBENCLAMIDE 5MGLUCORED FORTE TABLETS (GLIBENCLAMIDE 5M | $54.1K | 5 | 0.1% |
| 13 | UNIMED HEALTHCARE PTY LTDSOUTH AFRICA GLIBENCLAMIDE 5 OETHMAAN TABLETS PRP56GLIBENCLAMIDE 5 OETHMAANTABLETS PRP56GLIBENWISE 5 (GLIBENCLAMIDE TABLETS BP 5 | $53.3K | 5 | 0.1% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Glibenclamide — and from which countries?
Flow of Glibenclamide exports from India: each country's share and the named importers behind the numbers
Glibenclamide — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Sri Lanka
Sri Lanka emerges as the first largest importing country, achieving a total trade value of $37.0M through 2 shipments. This represents a market share of 89.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Sri Lanka has a diverse importer base, with their top importers including:
• A,BAUR & CO,(PVT,) LTD - $37.0M (100.0% of country's total business)
Key Insight: Sri Lanka demonstrates strong market positioning with an average shipment value of $18.5M, indicating premium pricing strategy compared to the market average of $44.3K.
Sri Lanka is a key market for Glibenclamide imports, representing 89.8% of total trade value.
2Tanzania
Tanzania emerges as the second largest importing country, achieving a total trade value of $656.4K through 4 shipments. This represents a market share of 1.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Tanzania has a diverse importer base, with their top importers including:
• HEKO PHARMACY LTD - $54.1K (8.2% of country's total business)
Key Insight: Tanzania demonstrates strong market positioning with an average shipment value of $164.1K, indicating premium pricing strategy compared to the market average of $44.3K.
Tanzania is a key market for Glibenclamide imports, representing 1.6% of total trade value.
3Russia
Russia emerges as the third largest importing country, achieving a total trade value of $475.8K through 7 shipments. This represents a market share of 1.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Russia has a diverse importer base, with their top importers including:
• PJSC PHARMSTANDARD-TOMSKHIMPHARM - $183.7K (38.6% of country's total business)
• PJSC "PHARMSTANDARD-TOMSKHIMPHARM" - $116.3K (24.4% of country's total business)
Key Insight: Russia demonstrates strong market positioning with an average shipment value of $68.0K, indicating premium pricing strategy compared to the market average of $44.3K.
Russia is a key market for Glibenclamide imports, representing 1.2% of total trade value.
4South Africa
South Africa emerges as the fourth largest importing country, achieving a total trade value of $469.0K through 25 shipments. This represents a market share of 1.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: South Africa has a diverse importer base, with their top importers including:
• OETHMAAN BIOSIMS PTY LIMITED - $114.5K (24.4% of country's total business)
• BIOTECH LABORATORIES (PTY) LTD - $81.1K (17.3% of country's total business)
• OETHMAAN BIOSIMS PTY LTD - $69.2K (14.8% of country's total business)
• XXTHMXXN BXXSIMXXPTYXXTD - $61.5K (13.1% of country's total business)
• UNIMED HEALTHCARE PTY LTD - $53.3K (11.4% of country's total business)
• Rest of South Africa's importers - $89.4K (19.1% of country's total business)
Key Insight: South Africa demonstrates strong market positioning with an average shipment value of $18.8K, indicating competitive pricing strategy compared to the market average of $44.3K.
South Africa is a key market for Glibenclamide imports, representing 1.1% of total trade value.
5Cambodia
Cambodia emerges as the fifth largest importing country, achieving a total trade value of $285.8K through 0 shipments. This represents a market share of 0.7% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Cambodia demonstrates strong market positioning with an average shipment value of $285.8K, indicating premium pricing strategy compared to the market average of $44.3K.
Cambodia is a key market for Glibenclamide imports, representing 0.7% of total trade value.
Buyer Segment Analysis
TransData Nexus Glibenclamide buyer market intelligence
1Buyer Segment Analysis
The importers of Glibenclamide from India can be categorized into several segments:
- 1Distributors: Entities that purchase pharmaceuticals in bulk to supply to various healthcare providers.
- 2Hospital Groups: Healthcare institutions procuring medications for inpatient and outpatient care.
- 3Retail Chains: Pharmacy chains acquiring medicines for direct consumer sales.
- 4Government Procurement: Organizations like UNICEF, the Global Fund, or national health departments involved in large-scale purchasing for public health initiatives.
- 5Re-exporters: Companies importing products for the purpose of exporting them to other markets.
- 6Contract Manufacturers: Firms that produce pharmaceuticals on behalf of other companies, which may include sourcing active pharmaceutical ingredients (APIs) like Glibenclamide.
Based on our data, the top 10 buyers of Glibenclamide from India are:
- 1A. Baur & Co. (Pvt.) Ltd (Sri Lanka): $36.98M
- 2PJSC Pharmstandard-Tomskhimpharm (Russia): $0.18M
- 3Opham (Madagascar): $0.18M
- 4M/s. Imres (Netherlands): $0.14M
- 5PJSC "Pharmstandard-Tomskhimpharm" (Russia): $0.12M
- 6Oethmaan Biosims Pty Limited (South Africa): $0.11M
- 7Biotech Laboratories (Pty) Ltd (South Africa): $0.08M
- 8Oethmaan Biosims Pty Ltd (South Africa): $0.07M
- 9XXTHMXXN BXXSIMXXPTYXXTD (South Africa): $0.06M
- 10Saudi Hospital in Hajjah SHH (Yemen): $0.06M
Analyzing these buyers:
- A. Baur & Co. (Pvt.) Ltd: As the predominant buyer, accounting for 89.8% of total exports, this entity likely functions as a major distributor in Sri Lanka, supplying Glibenclamide to various healthcare providers and retail pharmacies.
- PJSC Pharmstandard-Tomskhimpharm: This Russian company appears twice, suggesting it operates both as a distributor and possibly a contract manufacturer, sourcing Glibenclamide for domestic production or distribution.
- Opham: Based in Madagascar, Opham is likely a distributor supplying the local market.
- M/s. Imres: Operating from the Netherlands, Imres may act as a re-exporter or distributor, potentially supplying Glibenclamide to various regions.
- Oethmaan Biosims Pty Limited and Biotech Laboratories (Pty) Ltd: These South African entities are likely distributors or contract manufacturers, procuring Glibenclamide for local distribution or pharmaceutical production.
- Saudi Hospital in Hajjah SHH: This Yemeni hospital's direct procurement indicates a hospital group segment, acquiring Glibenclamide for patient care.
Typical buying behaviors vary by segment. Distributors and retail chains often place large, periodic orders to maintain inventory levels, while hospital groups may order based on patient demand and treatment protocols. Government procurement agencies typically engage in tender-based purchasing, securing large quantities at negotiated prices. Re-exporters focus on market demands in their target regions, and contract manufacturers procure APIs like Glibenclamide based on production schedules and client requirements.
Country-Specific Import Regulations
TransData Nexus Glibenclamide buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Glibenclamide are as follows:
1. Sri Lanka:
2. Tanzania:
3. Russia:
4. South Africa:
5. Cambodia:
Demand Drivers & Market Opportunity
TransData Nexus Glibenclamide buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Glibenclamide in importing countries is primarily driven by the prevalence of type 2 diabetes mellitus, for which Glibenclamide is a commonly prescribed medication. According to the World Health Organization (WHO), the global prevalence of diabetes among adults over 18 years of age was 8.5% in 2014, with a rising trend observed in subsequent years. This increasing prevalence necessitates a steady supply of antidiabetic medications like Glibenclamide.
Government healthcare programs and the expansion of universal health coverage also contribute significantly to the demand. Many countries include Glibenclamide in their national essential medicines lists, aligning with the WHO Essential Medicines List, which facilitates procurement through government tenders and international organizations. The presence of 335 buyers across 100 countries, as per our data, underscores the widespread reliance on Glibenclamide to meet public health needs.
Common Questions — Glibenclamide Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest glibenclamide buyer importing from India?
Based on import volume and value, A,BAUR & CO,(PVT,) LTD (SRI LANKA) leads with $37.0M in imports and a 89.7% market share — the highest of any single glibenclamide importer. PJSC PHARMSTANDARD-TOMSKHIMPHARM (RUSSIA) and OPHAM (MADAGASCAR) are the next largest buyers.
QHow many companies buy glibenclamide from India?
There are 335 active glibenclamide buyers importing from India, with a combined market of $41.2M across 930 shipments to 100 countries. The top 5 buyers hold 91.3% of total import value, while the remaining 330 buyers handle the other 8.7%.
QWhich countries import the most glibenclamide from India?
The top importing countries for glibenclamide from India are Sri Lanka (89.8%), Tanzania (1.6%), Russia (1.2%), South Africa (1.1%), Cambodia (0.7%). These markets represent the largest demand centres for Indian pharmaceutical exports of glibenclamide, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for glibenclamide from India?
The average import transaction value for glibenclamide from India is $44.3K, with an average unit price of $1.47 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Glibenclamide buyer market intelligence
1Buyer Segment Analysis
The importers of Glibenclamide from India can be categorized into several segments:
- 1Distributors: Entities that purchase pharmaceuticals in bulk to supply to various healthcare providers.
- 2Hospital Groups: Healthcare institutions procuring medications for inpatient and outpatient care.
- 3Retail Chains: Pharmacy chains acquiring medicines for direct consumer sales.
- 4Government Procurement: Organizations like UNICEF, the Global Fund, or national health departments involved in large-scale purchasing for public health initiatives.
- 5Re-exporters: Companies importing products for the purpose of exporting them to other markets.
- 6Contract Manufacturers: Firms that produce pharmaceuticals on behalf of other companies, which may include sourcing active pharmaceutical ingredients (APIs) like Glibenclamide.
Based on our data, the top 10 buyers of Glibenclamide from India are:
- 1A. Baur & Co. (Pvt.) Ltd (Sri Lanka): $36.98M
- 2PJSC Pharmstandard-Tomskhimpharm (Russia): $0.18M
- 3Opham (Madagascar): $0.18M
- 4M/s. Imres (Netherlands): $0.14M
- 5PJSC "Pharmstandard-Tomskhimpharm" (Russia): $0.12M
- 6Oethmaan Biosims Pty Limited (South Africa): $0.11M
- 7Biotech Laboratories (Pty) Ltd (South Africa): $0.08M
- 8Oethmaan Biosims Pty Ltd (South Africa): $0.07M
- 9XXTHMXXN BXXSIMXXPTYXXTD (South Africa): $0.06M
- 10Saudi Hospital in Hajjah SHH (Yemen): $0.06M
Analyzing these buyers:
- A. Baur & Co. (Pvt.) Ltd: As the predominant buyer, accounting for 89.8% of total exports, this entity likely functions as a major distributor in Sri Lanka, supplying Glibenclamide to various healthcare providers and retail pharmacies.
- PJSC Pharmstandard-Tomskhimpharm: This Russian company appears twice, suggesting it operates both as a distributor and possibly a contract manufacturer, sourcing Glibenclamide for domestic production or distribution.
- Opham: Based in Madagascar, Opham is likely a distributor supplying the local market.
- M/s. Imres: Operating from the Netherlands, Imres may act as a re-exporter or distributor, potentially supplying Glibenclamide to various regions.
- Oethmaan Biosims Pty Limited and Biotech Laboratories (Pty) Ltd: These South African entities are likely distributors or contract manufacturers, procuring Glibenclamide for local distribution or pharmaceutical production.
- Saudi Hospital in Hajjah SHH: This Yemeni hospital's direct procurement indicates a hospital group segment, acquiring Glibenclamide for patient care.
Typical buying behaviors vary by segment. Distributors and retail chains often place large, periodic orders to maintain inventory levels, while hospital groups may order based on patient demand and treatment protocols. Government procurement agencies typically engage in tender-based purchasing, securing large quantities at negotiated prices. Re-exporters focus on market demands in their target regions, and contract manufacturers procure APIs like Glibenclamide based on production schedules and client requirements.
Country-Specific Import Regulations
TransData Nexus Glibenclamide buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Glibenclamide are as follows:
1. Sri Lanka:
2. Tanzania:
3. Russia:
4. South Africa:
5. Cambodia:
Demand Drivers & Market Opportunity
TransData Nexus Glibenclamide buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Glibenclamide in importing countries is primarily driven by the prevalence of type 2 diabetes mellitus, for which Glibenclamide is a commonly prescribed medication. According to the World Health Organization (WHO), the global prevalence of diabetes among adults over 18 years of age was 8.5% in 2014, with a rising trend observed in subsequent years. This increasing prevalence necessitates a steady supply of antidiabetic medications like Glibenclamide.
Government healthcare programs and the expansion of universal health coverage also contribute significantly to the demand. Many countries include Glibenclamide in their national essential medicines lists, aligning with the WHO Essential Medicines List, which facilitates procurement through government tenders and international organizations. The presence of 335 buyers across 100 countries, as per our data, underscores the widespread reliance on Glibenclamide to meet public health needs.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 335 global importers of Glibenclamide identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 930 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 100 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
930 Verified Shipments
335 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists